Medicines Evaluation Unit Ltd

meu.org.uk

The Medicines Evaluation Unit (MEU) Ltd, is one of the UK’s leading contract research organisations, a facility where commitment to excellence is paramount. Possessing extensive pharmaceutical, scientific and clinical expertise, within a state-of-the-art hospital-based research facility, allied with fast volunteer recruitment rates, enables MEU to offer clients positive clinical trial solutions. The MEU’s core skill area is in respiratory clinical trials, together with early phase exploratory studies. This is enhanced by the specialist support offered by collaboration with the University Hospital of South Manchester, and its extensive facilities.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

Research, PHARMA TECH

BIOCYTOGEN ANNOUNCES NON-EXCLUSIVE LICENSE AGREEMENT WITH JANSSEN BIOTECH

Biocytogen | March 09, 2023

news image

On March 8, 2023, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen) announced a non-exclusive license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen). The deal was facilitated by Johnson & Johnson Innovation LLC. Under the agreement, Janssen and its affiliates have been granted a global, non-exclusive license to utilize Biocytogen's RenLite® platform and its underlying intellectual propert...

Read More

HOW AI IS HELPING PHARMA COPE WITH SUPPLY CHAIN DISRUPTION

EPM Magazine | June 25, 2020

news image

As the Covid-19 crisis continues to unsettle global economies and business sectors worldwide, pharma companies are facing huge disruption to their supply chains and clinical research. And while research into potential Covid-19 vaccines and treatments is speeding along, the pandemic has slowed or brought to a halt clinical trials for other diseases, with organisations like Eli Lilly and other big name pharma’s’ putting the brakes on non Covid-19 trial activity. In fact,...

Read More

Pharma Tech

ANGELINI PHARMA SELECTS AIDEA’S ARTIFICIAL INTELLIGENCE TO BOOST ITS GROWTH

Angelini Pharma | March 11, 2021

news image

Trueblue, a main supplier of AI answers for Operational and Analytical CRM in the Life Science industry reports that Angelini Pharma, as a feature of a significant global computerized change measure, has picked AiDEA, the principal AI-Digital Cloud Pharma CRM arrangement dependent on Microsoft Dynamics 365. Angelini Pharma is a main pharmaceutical organization focused on aiding patients in the remedial zones of Central Nervous System (CNS) and Mental Health (including Pain), Rare Diseases and Co...

Read More

WAREHOUSE OPTIMIZATION HELPED A PHARMA COMPANY TO INTEGRATE DATA FROM DISPARATE SOURCE WITHIN THE SUPPLY CHAIN

Businesswire | May 07, 2020

news image

Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has announced the completion of its recent engagement which examines the role of warehouse optimization in the pharma industry. This success story offers comprehensive insights into how Quantzig helped a pharma company who was facing a multitude of warehouse optimization and distribution challenges that were further complicated by the nature of the drugs that the...

Read More
news image

Research, PHARMA TECH

BIOCYTOGEN ANNOUNCES NON-EXCLUSIVE LICENSE AGREEMENT WITH JANSSEN BIOTECH

Biocytogen | March 09, 2023

On March 8, 2023, Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen) announced a non-exclusive license agreement with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen). The deal was facilitated by Johnson & Johnson Innovation LLC. Under the agreement, Janssen and its affiliates have been granted a global, non-exclusive license to utilize Biocytogen's RenLite® platform and its underlying intellectual propert...

Read More
news image

HOW AI IS HELPING PHARMA COPE WITH SUPPLY CHAIN DISRUPTION

EPM Magazine | June 25, 2020

As the Covid-19 crisis continues to unsettle global economies and business sectors worldwide, pharma companies are facing huge disruption to their supply chains and clinical research. And while research into potential Covid-19 vaccines and treatments is speeding along, the pandemic has slowed or brought to a halt clinical trials for other diseases, with organisations like Eli Lilly and other big name pharma’s’ putting the brakes on non Covid-19 trial activity. In fact,...

Read More
news image

Pharma Tech

ANGELINI PHARMA SELECTS AIDEA’S ARTIFICIAL INTELLIGENCE TO BOOST ITS GROWTH

Angelini Pharma | March 11, 2021

Trueblue, a main supplier of AI answers for Operational and Analytical CRM in the Life Science industry reports that Angelini Pharma, as a feature of a significant global computerized change measure, has picked AiDEA, the principal AI-Digital Cloud Pharma CRM arrangement dependent on Microsoft Dynamics 365. Angelini Pharma is a main pharmaceutical organization focused on aiding patients in the remedial zones of Central Nervous System (CNS) and Mental Health (including Pain), Rare Diseases and Co...

Read More
news image

WAREHOUSE OPTIMIZATION HELPED A PHARMA COMPANY TO INTEGRATE DATA FROM DISPARATE SOURCE WITHIN THE SUPPLY CHAIN

Businesswire | May 07, 2020

Quantzig, a global data analytics and advisory firm, that delivers actionable analytics solutions to resolve complex business problems has announced the completion of its recent engagement which examines the role of warehouse optimization in the pharma industry. This success story offers comprehensive insights into how Quantzig helped a pharma company who was facing a multitude of warehouse optimization and distribution challenges that were further complicated by the nature of the drugs that the...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us